Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis
暂无分享,去创建一个
T. Fujisawa | K. Tatsumi | W. Takahashi | D. Ebner | H. Tsuji | K. Tsushima | M. Karube | T. Kamada | K. Hayashi | M. Nakajima | N. Yamamoto | Y. Tada | Makoto Anzai | T. Miyamoto
[1] Vasilis Aidinis,et al. Lung cancer in patients with idiopathic pulmonary fibrosis. , 2017, Pulmonary pharmacology & therapeutics.
[2] H. Tsujii,et al. A Dose Escalation Clinical Trial of Single‐Fraction Carbon Ion Radiotherapy for Peripheral Stage I Non–Small Cell Lung Cancer , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[3] R. Onimaru,et al. Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403. , 2015, International journal of radiation oncology, biology, physics.
[4] M. Tsuboi,et al. Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia. , 2015, The Annals of thoracic surgery.
[5] T. Fujisawa,et al. A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non–small cell lung cancer (NSCLC) , 2015, Cancer.
[6] K. Togashi,et al. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival after Stereotactic Body Radiation Therapy for Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[7] Kenji Suzuki,et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. , 2014, The Journal of thoracic and cardiovascular surgery.
[8] Y. Korogi,et al. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis. , 2013, Lung cancer.
[9] C. Stevens,et al. Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung. , 2012, International journal of radiation oncology, biology, physics.
[10] Mitsuhiro Nakamura,et al. Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. , 2012, International journal of radiation oncology, biology, physics.
[11] Kenji Suzuki,et al. The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[12] H. Collard,et al. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.
[13] K. Ohtomo,et al. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy , 2010, Radiation oncology.
[14] Andrea Bezjak,et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.
[15] G. Raghu,et al. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology , 2010, European Respiratory Journal.
[16] R. Barriger,et al. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. , 2009, International journal of radiation oncology, biology, physics.
[17] H. Shirato,et al. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group. , 2009, International journal of radiation oncology, biology, physics.
[18] K. Chida,et al. Cumulative incidence of and predictive factors for lung cancer in IPF , 2009, Respirology.
[19] Jan-Jakob Sonke,et al. Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[20] H. Tsujii,et al. Carbon ion radiotherapy for elderly patients 80 years and older with stage I non-small cell lung cancer. , 2009, Lung cancer.
[21] Susumu Kandatsu,et al. Carbon Ion Radiotherapy for Stage I Non-small Cell Lung Cancer Using a Regimen of Four Fractions during 1 Week , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[22] Ping Li,et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.
[23] Y. Onodera,et al. Mediastinal Lymph Node Staging by FDG-PET in Patients with Non-Small Cell Lung Cancer: Analysis of False-Positive FDG-PET Findings , 2003, Respiration.
[24] Koichiro Tatsumi,et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. , 2003, The Journal of thoracic and cardiovascular surgery.
[25] Demosthenes Bouros,et al. Association of malignancy with diseases causing interstitial pulmonary changes. , 2002, Chest.
[26] P. Valk,et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. , 2000, The Annals of thoracic surgery.
[27] S Minohara,et al. Respiratory gated irradiation system for heavy-ion radiotherapy. , 2000, International journal of radiation oncology, biology, physics.
[28] M. Hara,et al. Iung cancer associated with usual interstitial pneumonia , 1995, Pathology international.
[29] V. Poletti,et al. The impact of lung cancer on survival of idiopathic pulmonary fibrosis. , 2015, Chest.
[30] Y. Sugiyama,et al. Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases. , 2015, The Journal of thoracic and cardiovascular surgery.
[31] L. Voltolini,et al. Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[32] Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. , 2004, Thorax.
[33] D. Forman,et al. Delays in managing lung cancer. , 2004, Thorax.
[34] T Kanai,et al. Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy. , 1997, Radiation research.